DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
Helium One Global (LON:HE1) CEO David Minchin joins DirectorsTalk Interviews to discuss the successful completion of a third-party engineering audit on the operational capability of the Company’s preferred drilling rig..
Symphony Environmental Technologies Plc (LON:SYM) Director Michael Stephen joins DirectorsTalk Interviews to discuss the United Nations International Plastics Treaty. Michael shares his thoughts on the treaty, explains why they are..
CLO income fund Volta Finance Ltd (LON:VTA, LON:VTAS) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk Interviews. Mark talks us through his report entitled..
Fidelity European Trust (LON:FEV) is the topic of conversation when Analyst at Hardman & Co Riccardo Bindi joins DirectorsTalk Interviews. Riccardo talks us through his note that was just published..
Oakley Capital Investments (LON:OCI) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews to discuss his recent note entitled 1H’22: results prove NAV..
nanosynth Group plc (LON:NNN) CEO Mark Duffin joins DirectorsTalk Interviews to discuss its half yearly report for the six-month period ended 30 June 2022. Mark talks us through the trial..
R&Q Insurance Holdings Limited (LON:RQIH) overview, investment case and progress presented by William Spiegel (Chairman) and Tom Solomon (CFO). R&Q Insurance Holdings Limited (LON: RQIH), headquartered and operating in Bermuda with..
Symphony Environmental Technologies plc (LON:SYM) CFO Ian Bristow joins DirectorsTalk Interviews to its financial results for the six-month period ended 30 June 2022. Ian takes us through the key financial..
Fidelity China Special Situations (LON:FCSS) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark gives us a summary of his report entitled..
Zinc Media Group (LON:ZIN) CEO Mark Browning joins DirectorsTalk Interviews to discuss its interim results for the six months to 30 June 2022. Mark talks us through the highlights, with..
Avingtrans PLC (LON:AVG) CEO Steve McQuillan joins DirectorsTalk Interviews to discuss its results for the year ended 31st May 2022. Steve talks us through the highlights, the performance and highlights..
Billington Holdings PLC (LON:BILN) CEO Mark Smith and CFO Trevor Taylor join DirectorsTalk Interviews to discuss interim results for the six months ended 30 June 2022. Trevor talks us through..
Silver Bullet Data Services Group plc (LON:SBDS) CEO Ian James joins DirectorsTalk Interviews to discuss interim results for the six months to 30 June 2022. Ian talks us through the..
Boku, Inc (LON:BOKU) CEO Jon Prideaux joins DirectorsTalk Interviews to discuss interim results for the six months ended 30th June 2022. Jon talks us through the highlights of the period,..
Eden Research plc (LON:EDEN) CEO Sean Smith joins DirectorsTalk Interviews to discuss approval from the United States Environmental Protection Agency (EPA), for all of its five petitions submitted Sean talks..
Concurrent Technologies plc (LON:CNC) CEO Miles Adcock and CFO Kim Garrod join DirectorsTalk Interviews to discuss interim results for the six months ended 30th June 2022. Topics covered are order..
Pennant International Group plc (LON:PEN), CEO Phil Walker joins DirectorsTalk Interviews to discuss its Interim Results for the six months ended 30th June 2022. Phil talks us through the key..
itim Group plc (LON:ITIM) CEO Ali Athar joins DirectorsTalk Interviews to discuss interim results for the period ended 30th June 2022. Ali talks us through the highlights, explains how itim..
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced the following update regarding the Company’s NXP002 programme, a proprietary..
Strix Group plc (LON:KETL) CEO Bark Bartlett joins DirectorsTalk Interviews to discuss its interim results for the six months ended 30th June 2022. Mark talks us through the highlights for..
